Notox Developing a Drug-Free Pain Management Apparatus to Assist Veterans in Managing Pain Without Drugs or Opioids

Richmond Hill, Ontario--(Newsfile Corp. - February 11, 2019) - Notox Technologies Corp. (OTCQB: NTOX), a Nevada corporation in the business of developing and commercializing innovative technologies (the "Company"), is pleased to announce that it has entered into a relationship with the Veterans Global Initiative Foundation to raise capital for the testing, development and commercialization of the Company's drug-free pain management solutions, primarily for the benefit of military veterans who suffer from pain. The Company and the VGI Foundation are working together to provide the Notox treatment either at no cost or at deeply discounted rates to those veterans who need relief the most and continue to suffer in cases where other treatments have failed.

As previously announced, over the past two years the Company has transitioned into developing, commercializing and promoting its patented Notox aesthetic and drug-free pain management platform, following its acquisition of the associated intellectual property rights in 2016. That patented intellectual property was originally developed by Dr. Frank Papay, MD FACS Chairman Dermatology and Plastic Surgery Institute, Cleveland Clinic, and is owned by The Cleveland Clinic Foundation.

"Since our last announcement we have been positioning the Company and developing strategies to advance the Notox technology as quickly as possible," stated Zoran Konević, the Company's Chief Executive Officer. "Teaming up with the VGI Foundation to bring our platform to market and provide relief to veterans in the USA and around the world is a dream come true. Nobody should need to use drugs such as opioids to deal with the types of pain that Notox is capable of managing. We are overjoyed to be able to contribute and give back to veterans and active duty personal who risked their lives for our safety."

About Notox Technologies Corp.

Notox Technologies Corp. (OTCQB: NTOX) is in the business of developing and commercializing innovative technologies primarily through its wholly-owned Nevada subsidiary Notox Bioscience Inc. The Company's goals are to market a credible, non-toxic alternative to Botox and subsequently develop other features of its Notox technology such as drug-free pain management, body countering, skin tightening and anti-perspiration.

About Veterans Global Initiative Foundation

The Veterans Global Initiative Foundation is an American organization with a clear mandate to better veterans' quality of life by assisting veterans, active duty service members and their immediate families in their quest for better living conditions. This includes promoting advances in education, temporary and permanent employment, housing, and R&D towards drug-free treatments, equipment and management solutions related to pain, PTSD and other health disorders, among other initiatives.

For more information, please contact:

Zoran Konevic - CEO

Safe Harbor Statement and Forward-Looking Statements

This news release may contain forward-looking statements that involve known and unknown risks, uncertainties and other factors which may cause the Company's actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements. Forward-looking statements reflect the Company's current views with respect to future events and are based on assumptions and subject to risks and uncertainties. Given these uncertainties, investors should not place undue reliance on these forward-looking statements. Such statements may include, but are not limited to, information related to: anticipated operating results; relationships with customers and strategic partners; consumer demand; financial resources and condition; the ability to list any securities for trading on a recognized exchange; changes in revenues; changes in profitability; changes in accounting treatment; changes in management; cost of sales; selling, general and administrative expenses; interest expense; the ability to produce the liquidity or enter into agreements to acquire the capital necessary to continue operations and take advantage of opportunities; and legal proceedings and claims. Except as required by law, the Company assumes no obligation to update any forward-looking statements publicly, or to update the reasons actual results could differ materially from those anticipated in any forward-looking statements, even if new information becomes available in the future.

To view the source version of this press release, please visit